Isoniazid and Rifampin

The Department of Health and Human Services (DHHS) Supply Service Center in Perry Point, Maryland is seeking sources for pharmaceutical products through this Pre-Solicitation Notice. Specifically, the agency is procuring Isoniazid tablets at 300 mg strength and Rifampin tablets at 300 mg strength to support its operations. This is a civilian procurement classified under the Pharmaceutical and Medicine Manufacturing NAICS category (3254) and the Drugs and Biologicals PSC category (6505). The Pre-Solicitation Notice was posted on April 7, 2026, with a response deadline of April 21, 2026, providing interested vendors with 14 calendar days to submit inquiries or indicate their interest in bidding. While specific evaluation criteria are not detailed in this notice, vendors should anticipate that quality, pricing, delivery capability, and manufacturing compliance standards will likely factor into the government's assessment.

This procurement opportunity is designated as a Total Small Business set-aside, meaning only small businesses as defined by the Small Business Administration are eligible to compete for this contract. The government seeks 7,500 bottles of Isoniazid 300 mg tablets in 30-count bottles and 7,500 bottles of Rifampin 300 mg tablets in 60-count bottles, representing a substantial volume commitment. No specific budget range or award value is disclosed in this Pre-Solicitation Notice, nor are there any identified incumbent contractors mentioned. The notice does not specify a contract duration, but interested vendors should prepare to demonstrate their manufacturing capabilities, quality assurance protocols, and ability to meet the stated quantity requirements. Vendors should monitor the Federal Procurement Data System and agency websites for the formal solicitation release, which typically follows a Pre-Solicitation Notice within a defined timeframe.